BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jafari M, Abolmaali SS, Tamaddon AM, Zomorodian K, Sarkari BS. Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine (Lond) 2021;16:857-77. [PMID: 33890492 DOI: 10.2217/nnm-2020-0482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mansur-Alves I, Lima BLF, Santos TT, Araújo NF, Frézard F, Islam A, de Barros AL, Dos Santos DC, Fernandes C, Ferreira LA, Aguiar MM. Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis. Nanomedicine (Lond) 2022. [PMID: 36189757 DOI: 10.2217/nnm-2021-0489] [Reference Citation Analysis]
2 Zareshahrabadi Z, Khorram M, Pakshir K, Tamaddon A, Jafari M, Nouraei H, Ardekani NT, Amirzadeh N, Irajie C, Barzegar A, Iraji A, Zomorodian K. Magnetic chitosan nanoparticles loaded with Amphotericin B: Synthesis, properties and potentiation of antifungal activity against common human pathogenic fungal strains. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.09.244] [Reference Citation Analysis]
3 Jafari M, Abolmaali SS, Borandeh S, Najafi H, Zareshahrabadi Z, Heidari R, Azarpira N, Zomorodian K, Tamaddon AM. Amphiphilic hyperbranched polyglycerol nanoarchitectures for Amphotericin B delivery in Candida infections. Biomaterials Advances 2022;139:212996. [DOI: 10.1016/j.bioadv.2022.212996] [Reference Citation Analysis]
4 Khosravi A, Sharifi I, Tavakkoli H, Molaakbari E, Bahraminegad S, Salarkia E, Seyedi F, Keyhani A, Salari Z, Sharifi F, Bamorovat M, Afgar A, Dabiri S. Cytotoxicity of Amphotericin B and AmBisome: In Silico and In Vivo Evaluation Employing the Chick Embryo Model. Front Pharmacol 2022;13:860598. [PMID: 35754489 DOI: 10.3389/fphar.2022.860598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Asdaq SMB, Rajan A, Damodaran A, Kamath SR, Nair KS, Zachariah SM, Sahu RK, Fattepur S, Sreeharsha N, Nair A, Jacob S, Albahrani HA, Alkhaldi EH, Mohzari Y, Alrashed AA, Imran M. Identifying Mucormycosis Severity in Indian COVID-19 Patients: A Nano-Based Diagnosis and the Necessity for Critical Therapeutic Intervention. Antibiotics (Basel) 2021;10:1308. [PMID: 34827246 DOI: 10.3390/antibiotics10111308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]